FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Akio Hiraki

Research Profile

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Yoshiko Ogata; Hiroshi Ueoka; Keisuke Aoe; Kenichi Chikamori; Akio Hiraki; Daizo Kishino; Katsuyuki Kiura; Tadashi Maeda; Kazuo Murakami; Mitsune Tanimoto
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Yoshihiko Segawa; Katsuyuki Kiura; Nagio Takigawa; Haruhito Kamei; Shingo Harita; Shunkichi Hiraki; Y Watanabe; Keisuke Sugimoto; Takuo Shibayama; Toshiro Yonei; Hiroshi Ueoka; Mitsuhiro Takemoto; Susumu Kanazawa; Ichiro Takata; Naoyuki Nogami; Katsuyuki Hotta; Akio Hiraki; Masahiro Tabata; Keitaro Matsuo; Mitsune Tanimoto
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Hideki Katayama; Akio Hiraki; Keiichi Fujiwara; Keitaro Matsuo; Tadashi Maeda; Kenichi Chikamori; Daizo Kishino; Kazuo Tajima; Hiroshi Ueoka; Keisuke Aoe
Aberrant promoter methylation profile in pleural fluid DNA and clinicopathological factors in patients with non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Akio Hiraki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Yoshiko Ogata; Hiroshi Ueoka; Keisuke Aoe; Kenichi Chikamori; Akio Hiraki; Daizo Kishino; Katsuyuki Kiura; Tadashi Maeda; Kazuo Murakami; Mitsune Tanimoto
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Acta medica Okayama 2011;65(4):259-63.
2010: Yoshihiko Segawa; Katsuyuki Kiura; Nagio Takigawa; Haruhito Kamei; Shingo Harita; Shunkichi Hiraki; Y Watanabe; Keisuke Sugimoto; Takuo Shibayama; Toshiro Yonei; Hiroshi Ueoka; Mitsuhiro Takemoto; Susumu Kanazawa; Ichiro Takata; Naoyuki Nogami; Katsuyuki Hotta; Akio Hiraki; Masahiro Tabata; Keitaro Matsuo; Mitsune Tanimoto
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3299-306.
2007: Hideki Katayama; Akio Hiraki; Keiichi Fujiwara; Keitaro Matsuo; Tadashi Maeda; Kenichi Chikamori; Daizo Kishino; Kazuo Tajima; Hiroshi Ueoka; Keisuke Aoe
Aberrant promoter methylation profile in pleural fluid DNA and clinicopathological factors in patients with non-small cell lung cancer.
Asian Pacific journal of cancer prevention : APJCP 2007;8(2):221-4.
2006: Keisuke Aoe; Akio Hiraki; Takehiro Tanaka; Kenichi Gemba; Koji Taguchi; Tomoyuki Murakami; Naoko Sueoka; Toshiaki Kamei; Hiroshi Ueoka; Kazuro Sugi; Tadashi Yoshino; Takumi Kishimoto
Expression of vascular endothelial growth factor in malignant mesothelioma.
Anticancer research 2006;26(6C):4833-6.
2005: Keisuke Aoe; Akio Hiraki; Tadashi Maeda; Hideki Katayama; Keiichi Fujiwara; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto
Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer.
Internal medicine (Tokyo, Japan) 2005;44(8):800-4.
2004: Akio Hiraki; Hiroshi Ueoka; Ichiro Takata; Kenichi Gemba; Akihiro Bessho; Yoshihiko Segawa; Katsuyuki Kiura; Kenji Eguchi; Toshiyuki Yoneda; Mitsune Tanimoto; Mine Harada
Hypercalcemia-leukocytosis syndrome associated with lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;43(3):301-7.
2004: Keisuke Aoe; Akio Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Motoyuki Tanaka; Mitsune Tanimoto
Thrombocytosis as a useful prognostic indicator in patients with lung cancer.
Respiration; international review of thoracic diseases 2004;71(2):170-3.
2003: Akio Hiraki; Hiroshi Ueoka; Kenichi Gemba; Shoichi Kuyama; Daizo Kishino; Masahiro Tabata; Katsuyuki Kiura; Mitsune Tanimoto; Mine Harada
Hydronephrosis as a complication of adenocarcinoma of the lung.
Anticancer research 2003;23(3C):2915-6.
2003: Nagio Takigawa; Keiichi Fujiwara; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Akio Hiraki; Takuo Shibayama; Yoshihiko Segawa; Haruhito Kamei; Shunkichi Hiraki; Mitsune Tanimoto; Mine Harada
Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study.
Anticancer research 2003;23(1B):557-60.
2002: Noriko Namba; Akio Hiraki; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Tadashi Yoshino; Mitsune Tanimoto
Axillary metastasis as the first manifestation of occult breast cancer in a man: a case report.
Anticancer research 2002;22(6B):3611-3.
2002: Akio Hiraki; Hiroshi Ueoka; Akihiro Bessho; Yoshihiko Segawa; Nagio Takigawa; Katsuyuki Kiura; Kenji Eguchi; Toshiyuki Yoneda; Mitsune Tanimoto; Mine Harada
Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
Cancer 2002;95(8):1706-13.
2002: Nobuharu Fujii; Takashi Ikeda; Kazuma Ikeda; Akio Hiraki; Kimihiko Kawakami; Kozo Masuda; Yoshinobu Maeda; Kiyohiko Hatake; Kazuo Motoyoshi; Mine Harada; Mitsune Tanimoto
Differentiation of monoblastic cell line UG3 into leukemic dendritic cells.
International journal of oncology 2002;21(3):617-20.
2002: Motoyuki Tanaka; Akio Hiraki; Hiroshi Ueoka; Akihiro Bessho; Katsuyuki Kiura; Nagio Takigawa; Tsuyoshi Kodani; Kazuyo Miyatake; Noboru Hamada; Takumi Kishimoto; Mitsune Tanimoto; Mine Harada
Gingival metastasis in lung cancer.
Oncology reports 2002;9(3):571-4.
2002: Noriyuki Suzaki; Akio Hiraki; Hiroshi Ueoka; Motoi Aoe; Nagio Takigawa; Taizo Kishino; Katsuyuki Kiura; Arihiko Kanehiro; Mitsune Tanimoto; Mine Harada
Gastric perforation due to metastasis from adenocarcinoma of the lung.
Anticancer research 2002;22(2B):1209-12.
2002: Akio Hiraki; Katsuyuki Kiura; Hiromichi Yamane; Naoyuki Nogami; Masahiro Tabata; Nagio Takigawa; Hiroshi Ueoka; Mitsune Tanimoto; Mine Harada
Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):329-33.
2002: Haruyuki Kawai; Katsuyuki Kiura; Masahiro Tabata; Tadashi Yoshino; Ichiro Takata; Akio Hiraki; Kenichi Chikamori; Hiroshi Ueoka; Mitsune Tanimoto; Mine Harada
Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):305-14.
2001: Kenji Nishii; Hiroshi Ueoka; Katsuyuki Kiura; Tsuyoshi Kodani; Masahiro Tabata; Takuo Shibayama; Kenichi Gemba; Takuji Kitajima; Akio Hiraki; Masashi Kawaraya; T Nakayama; Mine Harada
A case-control study of lung cancer screening in Okayama Prefecture, Japan.
Lung cancer (Amsterdam, Netherlands) 2001;34(3):325-32.
2001: Nobukazu Fujimoto; Akio Hiraki; Hiroshi Ueoka; Mine Harada
Metastasis to the penis in a patient with squamous cell carcinoma of the lung with a review of reported cases.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):149-52.
2000: T Maeda; Hiroshi Ueoka; Masahiro Tabata; Katsuyuki Kiura; Takuo Shibayama; Kenichi Gemba; Nagio Takigawa; Akio Hiraki; H Katayama; Mine Harada
Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.
Japanese journal of clinical oncology 2000;30(12):534-41.
2000: Nobukazu Fujimoto; Akio Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; Akihiro Bessho; Ichiro Takata; Yasushi Hiramatsu; K Ikeda; Mine Harada
Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2000;30(2):145-8.
1999: Hiromichi Yamane; Akihiro Bessho; Katsuyuki Kiura; Masahiro Tabata; Y Katayama; K Motoda; T Tsuchida; Naoyuki Nogami; Akio Hiraki; Hiroshi Ueoka; Mine Harada
Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer.
Internal medicine (Tokyo, Japan) 1999;38(11):892-5.
1999: Akihiro Bessho; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Kazutaka Sunami; Y Katayama; H Yamane; Akio Hiraki; Mine Harada
High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
Anticancer research 1999;19(1B):693-8.
1999: Akio Hiraki; Hiroshi Ueoka; Tadashi Yoshino; Kenichi Chikamori; K Onishi; Katsuyuki Kiura; Akihiro Bessho; J Mimoto; H Date; A Ando; N Shimizu; Mine Harada
Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
Oncology reports 1999;6(1):75-80.
1998: Akio Hiraki; Hiroshi Ueoka; Masahiro Tabata; Katsuyuki Kiura; Akihiro Bessho; Hiromichi Yamane; Naoyuki Nogami; Mine Harada
Spontaneous biloma as a complication of small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1998;19(2):127-30.
1997: Akio Hiraki; Masahiro Tabata; Hiroshi Ueoka; Katsuyuki Kiura; T Shibayama; H Yamane; Mine Harada
Direct intracerebral invasion from skull metastasis of large cell lung cancer.
Internal medicine (Tokyo, Japan) 1997;36(10):720-3.
1997: H Yamane; Katsuyuki Kiura; Masahiro Tabata; Akihiro Bessho; T Tsuchida; K Motoda; Akio Hiraki; Hiroshi Ueoka; Mine Harada
Small cell lung cancer can express CD34 antigen.
Anticancer research 1997;17(5A):3627-32.